Advertisement

Ads Placeholder
Loading...

Pharnext SA

ALPHA.PAEURONEXT
Healthcare
Biotechnology
0.00
0.00(0.00%)
U.S. Market opens in 56h 8m

Pharnext SA Fundamental Analysis

Pharnext SA (ALPHA.PA) shows moderate financial fundamentals with a PE ratio of -0.00, profit margin of -2751.74%, and ROE of 82.57%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

ROE82.57%
Cash Position8983.33%
PEG Ratio-0.00

Areas of Concern

Operating Margin-2388.76%
Current Ratio0.41
We analyze ALPHA.PA's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -257913.6/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-257913.6/100

We analyze ALPHA.PA's fundamental strength across five key dimensions:

Efficiency Score

Weak

ALPHA.PA struggles to generate sufficient returns from assets.

ROA > 10%
-6.60%

Valuation Score

Excellent

ALPHA.PA trades at attractive valuation levels.

PE < 25
-0.00
PEG Ratio < 2
-0.00

Growth Score

Weak

ALPHA.PA faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

ALPHA.PA shows balanced financial health with some risks.

Debt/Equity < 1
-0.77
Current Ratio > 1
0.41

Profitability Score

Weak

ALPHA.PA struggles to sustain strong margins.

ROE > 15%
82.57%
Net Margin ≥ 15%
-2751.74%
Positive Free Cash Flow
No

Key Financial Metrics

Is ALPHA.PA Expensive or Cheap?

P/E Ratio

ALPHA.PA trades at -0.00 times earnings. This suggests potential undervaluation.

-0.00

PEG Ratio

When adjusting for growth, ALPHA.PA's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Pharnext SA at -0.00 times its book value. This may indicate undervaluation.

-0.00

EV/EBITDA

Enterprise value stands at 1.02 times EBITDA. This is generally considered low.

1.02

How Well Does ALPHA.PA Make Money?

Net Profit Margin

For every $100 in sales, Pharnext SA keeps $-2751.74 as profit after all expenses.

-2751.74%

Operating Margin

Core operations generate -2388.76 in profit for every $100 in revenue, before interest and taxes.

-2388.76%

ROE

Management delivers $82.57 in profit for every $100 of shareholder equity.

82.57%

ROA

Pharnext SA generates $-6.60 in profit for every $100 in assets, demonstrating efficient asset deployment.

-6.60%

Following the Money - Real Cash Generation

Operating Cash Flow

Pharnext SA generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.

$0.00

Free Cash Flow

Pharnext SA generates weak or negative free cash flow of $0.00, restricting financial flexibility.

$0.00

FCF Per Share

Each share generates $0.00 in free cash annually.

$0.00

FCF Yield

ALPHA.PA converts 0.00% of its market value into free cash.

0.00%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.00

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.00

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.12

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-0.77

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.41

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.83

vs 25 benchmark

ROA

Return on assets percentage

-6.60

vs 25 benchmark

ROCE

Return on capital employed

4.48

vs 25 benchmark

How ALPHA.PA Stacks Against Its Sector Peers

MetricALPHA.PA ValueSector AveragePerformance
P/E Ratio-0.0028.45 Better (Cheaper)
ROE82.57%763.00% Weak
Net Margin-275174.20%-45265.00% (disorted) Weak
Debt/Equity-0.770.34 Strong (Low Leverage)
Current Ratio0.412795.60 Weak Liquidity
ROA-659.65%-16588.00% (disorted) Weak

ALPHA.PA outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Pharnext SA's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ